The 37th annual JP Morgen Healthcare conference is underway in San Francisco, and the news has already started flowing. The Arctic Aurora LifeScience team is on the ground, sending updates and reports back home. Follow the latest news by clicking on the hashtag #JPM2019
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
The conference is located in San Francisco every year in the beginning of January, this year from January 7 - 10.
All updates from San Francisco are collected under the tag #JPM2019 https://www.arctic.com/afm/no/tag/JPM2019
- Invest in Arctic Aurora LifeScience - Private Clients
- For institutional clients, please contact our Business Development team at Arctic Fund Management
Arctic Aurora LifeScience is an equity fund investing in global biotechnology and pharmaceutical companies. The fund is run by former portfolio manager in the Swedish Governmental Pension Fund AP3, Ulrica Bjerke, as well as Dr. Torbjørn Bjerke, both with 20 years of experience from the market. Arctic Aurora LifeScience was launched in May 2016 with both hedged and un-hedged share classes.
Past performance in Arctic Aurora LifeScience is no guarantee for future returns. Future returns depend on the market, fund manager skill, fund risk level, costs, among others. Performance in the fund may at times be negative and may for this fund vary considerably within periods.